Learning from Psychedelic-Assisted Therapy: A 3-Part Series

This webinar is the first in the “Learning from Psychedelic-Assisted Therapy” 3-part series with Ronald Siegel.

How can psychopharmacology help clinicians working in IFS? Explore how psychedelic-assisted therapy can help heal trauma by connecting us to the parts we try to bury.

Psychopharmacology and psychotherapy both have the potential to be revolutionized by psychedelic drugs. One of the ways that psychedelic drugs work is by helping us re-evaluate our habitual sense of self. Under the right conditions, they can connect us to others and to aspects of ourselves that we’ve tried to bury. In this way, they can help heal traumatic wounds.

Psychedelic drugs can help illuminate our attachment to limiting self-images and facilitate life-changing transpersonal experiences. Often, rather than finding one coherent, stable separate self, people discover multiple sub-personalities or parts. And each of these parts has its own history, needs, and injuries.

How might we work with these parts, both in the context of psychedelic-assisted psychotherapy and in other forms of treatment? Join Dr. Richard Schwartz, developer of Internal Family Systems (IFS), and Dr. Ron Siegel as they explore psychopharmacology and how psychedelic experiences can help us recognize and care for diverse parts of ourselves. They’ll also delve into how IFS methods might enhance and enrich psychedelic-assisted psychotherapy.

In this workshop, you’ll learn how to help clients embrace all their different parts with love, care, and understanding. This in turn can help heal old wounds and free up resources, allowing them to be more fully and flexibly present. This webinar will be useful to clinicians with or without prior experience with either the IFS model, psychedelic drugs, or deep knowledge of psychopharmacology.

This webinar is part of the “Learning from Psychedelic-Assisted Therapy” 3-part series with Ronald Siegel. 

Psychedelic-assisted psychotherapy is showing promise for conditions ranging from treatment-resistant depression to major depression. It’s also helping those coping with PTSD and end-of-life anxiety and addictions. Maladaptive personality traits are often being diminished while valued attributes such as social connectedness and empathy are showing sustained improvement.

The way these psychedelic medicines are used and the therapeutic context that maximizes their healing potential represent a radical departure from traditional psychiatric treatment. And this is a departure that can help us reimagine psychiatry as a healing art.

This workshop draws on traditional psychoanalytic techniques, meditation, intersubjective relational work, and certain indigenous healing practices. We’ll explore a novel psychotherapeutic approach that can complement and leverage psychedelic-assisted psychotherapy and healing.

This webinar will be led by Dr. Gita Vaid, a psychiatrist, psychoanalyst, and expert in ketamine-assisted psychotherapy. She will be joined by Dr. Ron Siegel, a psychologist with experience integrating mindfulness and compassion practices into therapy. Together they will guide participants through an exploration of this paradigm shift in healing. You’ll learn how psychedelic-assisted psychotherapy activates intrinsic healing potentials for repair and correction. You’ll also discover how it fosters integration of self states, improves resilience, and allows for enhanced creative expression and growth.

Through discussion and case vignettes, we’ll explore ketamine-assisted psychotherapy, the transformational process, and their implications for psychotherapy. We’ll also delve into the deployment of expanded states of consciousness for discovery, exploration, healing, and growth.

This webinar is part of the “Learning from Psychedelic-Assisted Therapy” 3-part series with Ronald Siegel. 

Of all the disorders for which psychedelic-assisted psychotherapy research shows promise, the most dramatic results to date are found with trauma therapy treatment.

In fact, a Phase III study using MDMA for serious trauma has yielded remarkable results. Reductions in symptoms greatly surpassed what has been seen with other interventions.

How does psychedelic-assisted psychotherapy work to resolve trauma? What are the mechanisms of action this type of trauma therapy illuminates? How can clinicians working in other modalities harness these mechanisms to enhance treatment? How might we cultivate the attitudes that are effective in psychedelic-assisted work without pharmacological assistance?

Join Dr. Bessel Van der Kolk, one of the world’s leading authorities on trauma therapy, and Dr. Ron Siegel, as they explore these questions.

You’ll learn how to help clients safely open to experiences that have been pushed out of awareness to heal trauma. This webinar will be useful to clinicians with or without prior experience in either trauma treatment or psychedelic-assisted therapy.